Evidence map›Paper›PMID 32206602›Full record

ReviewGland surgery2020

Adrenal incidentaloma: cardiovascular and metabolic effects of mild cortisol excess.

Alan Kelsall, Ahmed Iqbal, John Newell-Price

Registry-linked trialOpen access · diamondAbstract readReview
In one paragraph

Review in Gland surgery, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT07573163 (A Randomized Clinical Trial of Tirzepatide Following Adrenalectomy in Mild Autonomous Cortisol Secretion), which is not on this map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
2.2field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT07573163 phase2recruitingnot on this mapstarted 2026, after this paper: background citation

A Randomized Clinical Trial of Tirzepatide Following Adrenalectomy in Mild Autonomous Cortisol Secretion

TypeinterventionalSponsorAlaa SadaRan2026 to 2028Enrolled34ConditionsMild Autonomous Cortisol Secretion (MACS), Adrenalectomy, StatusArmsTirzepatide, Standard medical treatment
3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 16 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Alan KelsallDepartment of Oncology and Metabolism, The Medical School, University of Sheffield, Beech Hill Road, Sheffield, UK.
Ahmed IqbalDepartment of Oncology and Metabolism, The Medical School, University of Sheffield, Beech Hill Road, Sheffield, UK.
John Newell-PriceDepartment of Oncology and Metabolism, The Medical School, University of Sheffield, Beech Hill Road, Sheffield, UK.
University of Sheffield · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In the vast majority of cases adrenal incidentalomas (AI) are benign adrenocortical adenomas. They are present in up to 10% of the population over 70 years, with incidence increasing with age. Mild cortisol excess (MCE) in the context of AI is defined as autonomous cortisol secretion (ACS) in the absence of the classical clinical features of Cushing's syndrome. MCE has been reported in up to at least one third of patients with AI. Numerous studies have shown that MCE in AI is associated with increased cardiovascular events and mortality, likely to be consequent upon both hemodynamic changes and inflammatory pathways, and a worse metabolic phenotype characterized by: pancreatic β-cell dysfunction, insulin resistance, visceral obesity and dyslipidemia. There is currently no level 3 evidence from large intervention randomized controlled trials to guide management of MCE in AI, and there is a lack of predictive tools to allow stratification to intervention of only those patients who would benefit in terms of improved metabolic and cardiovascular end-points. Here, we describe the mal-effects of cortisol on cardiovascular and metabolic tissues and discuss management strategies based on current largely observational data.

Indexed as

Adrenal incidentalomas (AIs)adrenocorticotropic hormone (ACTH)autonomous cortisol secretion (ACS)mild cortisol excess (MCE)non-functioning adenoma (NFAI)overnight dexamethasone suppression test (ONDST)

Identifiers

PMID32206602
PMCPMC7082271
OpenAlexW2999323123

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.